Phase I study of 9-nitro-20(S)-camptothecin in combination with cisplatin for patients with advanced malignancies

C. F. Verschraegen; M. Vincent; J. L. Abbruzzese; D. Siegler; J. J. Kavanagh; E. Loyer; A. P. Kudelka; E. Rubin; Texas

doi:10.1111/j.1749-6632.2000.tb07061.x

Phase I study of 9-nitro-20(S)-camptothecin in combination with cisplatin for patients with advanced malignancies

C. F. Verschraegen
, M. Vincent
, J. L. Abbruzzese
, D. Siegler
, J. J. Kavanagh
, E. Loyer
, A. P. Kudelka
, E. Rubin
, Texas

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	345-348
Number of pages	4
Journal	Annals of the New York Academy of Sciences
Volume	922
DOIs	https://doi.org/10.1111/j.1749-6632.2000.tb07061.x
State	Published - 2000

Access to Document

10.1111/j.1749-6632.2000.tb07061.x

Cite this

@article{91cfd9ba1c8045edad1993a092f1a250,

title = "Phase I study of 9-nitro-20(S)-camptothecin in combination with cisplatin for patients with advanced malignancies",

author = "Verschraegen, \{C. F.\} and M. Vincent and Abbruzzese, \{J. L.\} and D. Siegler and Kavanagh, \{J. J.\} and E. Loyer and Kudelka, \{A. P.\} and E. Rubin and Texas",

year = "2000",

doi = "10.1111/j.1749-6632.2000.tb07061.x",

language = "English",

volume = "922",

pages = "345--348",

journal = "Annals of the New York Academy of Sciences",

issn = "0077-8923",

}

TY - JOUR

T1 - Phase I study of 9-nitro-20(S)-camptothecin in combination with cisplatin for patients with advanced malignancies

AU - Verschraegen, C. F.

AU - Vincent, M.

AU - Abbruzzese, J. L.

AU - Siegler, D.

AU - Kavanagh, J. J.

AU - Loyer, E.

AU - Kudelka, A. P.

AU - Rubin, E.

AU - Texas,

PY - 2000

Y1 - 2000

UR - https://www.scopus.com/pages/publications/0034502490

U2 - 10.1111/j.1749-6632.2000.tb07061.x

DO - 10.1111/j.1749-6632.2000.tb07061.x

M3 - Article

C2 - 11193919

AN - SCOPUS:0034502490

SN - 0077-8923

VL - 922

SP - 345

EP - 348

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

ER -

Phase I study of 9-nitro-20(S)-camptothecin in combination with cisplatin for patients with advanced malignancies

Access to Document

Other files and links

Cite this